# The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients

> **NCT07147335** · — · RECRUITING · sponsor: **The First Affiliated Hospital of University of South China** · enrollment: 800 (estimated)

## Conditions studied

- Cirrhosis
- Hepotacellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** serum AKR1B10 levels

## Key facts

- **NCT ID:** NCT07147335
- **Lead sponsor:** The First Affiliated Hospital of University of South China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-16
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07147335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07147335, "The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07147335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*